Khashayar Roshanzamir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Khashayar Roshanzamir has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Yeganeh Talebkhan
Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
2 shared publications Fatemeh Torkashvand
Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
1 shared publication- Fatemeh Torkashvand
Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
1 shared publication Hadi Ostadi
CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran
1 shared publication- Hadi Ostadi
CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran
1 shared publication Hanna Ghobadian
Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 1 September 2024
- Published by Apex Publishing in Iranian Biomedical Journal
- Vol. 28 (5) , 282-296
Optimization of Culture Conditions to Improve Follicle-Stimulating Hormone Production by CHO-DG44 Cells in Serum-Free Medium
Background: In the present study, we attempted to adapt an adherent and serum-dependent Chinese hamster ovary DG44 cell line to a serum-free suspension culture and optimize the culture condition to achieve a higher yield of recombinant human follicle stimulating hormone (r-hFSH) with acceptable quality. This approach helps to mitigate the risks associated ...
- 1 September 2024
- Published by Apex Publishing in Iranian Biomedical Journal
- Vol. 28 (5) , 282-296
Open AccessOptimization of Culture Conditions to Improve Follicle-Stimulating Hormone Production by CHO-DG44 Cells in Serum-Free Medium
Background: In the present study, we attempted to adapt an adherent and serum-dependent Chinese hamster ovary DG44 cell line to a serum-free suspension culture and optimize the culture condition to achieve a higher yield of recombinant human follicle stimulating hormone (r-hFSH) with acceptable quality. This approach helps to mitigate the risks associated ...
- Open Access
- 29 May 2024
- Vol. 28 (5 & 6) , 282-96
Optimization of Culture Conditions to Improve Follicle-Stimulating Hormone Production by CHO-DG44 Cells in Serum-Free Medium.
In the present study, we attempted to adapt an adherent and serum-dependent Chinese hamster ovary DG44 cell line to a serum-free suspension culture and optimize the culture condition to achieve a higher yield of r-hFSH with acceptable quality. This approach helps to mitigate the risks associated with blood-borne pathogens, reduces lot-to-lot variability, and lowers costs, making it suitable for industrial processing and scale-up. The cell adaptation was performed using different chemically defined SFM. This process was followed by optimization through statistical experimental design, focusing on selected physicochemical parameters, including chemical supplementation of the medium and temperature shift. Both small- and large-scale cultures were conducted to test the reproducibility of the optimized condition. The expressed protein was evaluated for comparability with the standard molecule according to the Pharmacopeia guidelines. RSM analysis indicated that supplementation of the culture medium with galactose and NaBu, along with a temperature downshift, were the main parameters leading to increased cell viability (10%), r-hFSH level (96%), and more importantly, the glycosylation content (49%) of r-hFSH compared to the control condition. As r-hFSH isoforms generated during in vivo post-translational modifications typically exhibit different serum/plasma half-lives and bioactivity due to their incorporated sialic acid content/glycosylation, further optimizations of r-hFSH production are necessary to enhance its biological activity. In this study, following a primary screening of the studied parameters, optimization of culture conditions based on selected parameters resulted in enhanced quality and quantity of the produced r-hFSH. However, further examination is necessary before transitioning to industrial production.
- 29 May 2024
- Vol. 28 (5 & 6) , 282-96
Open AccessOptimization of Culture Conditions to Improve Follicle-Stimulating Hormone Production by CHO-DG44 Cells in Serum-Free Medium.
In the present study, we attempted to adapt an adherent and serum-dependent Chinese hamster ovary DG44 cell line to a serum-free suspension culture and optimize the culture condition to achieve a higher yield of r-hFSH with acceptable quality. This approach helps to mitigate the risks associated with blood-borne pathogens, reduces lot-to-lot variability, and lowers costs, making it suitable for industrial processing and scale-up. The cell adaptation was performed using different chemically defined SFM. This process was followed by optimization through statistical experimental design, focusing on selected physicochemical parameters, including chemical supplementation of the medium and temperature shift. Both small- and large-scale cultures were conducted to test the reproducibility of the optimized condition. The expressed protein was evaluated for comparability with the standard molecule according to the Pharmacopeia guidelines. RSM analysis indicated that supplementation of the culture medium with galactose and NaBu, along with a temperature downshift, were the main parameters leading to increased cell viability (10%), r-hFSH level (96%), and more importantly, the glycosylation content (49%) of r-hFSH compared to the control condition. As r-hFSH isoforms generated during in vivo post-translational modifications typically exhibit different serum/plasma half-lives and bioactivity due to their incorporated sialic acid content/glycosylation, further optimizations of r-hFSH production are necessary to enhance its biological activity. In this study, following a primary screening of the studied parameters, optimization of culture conditions based on selected parameters resulted in enhanced quality and quantity of the produced r-hFSH. However, further examination is necessary before transitioning to industrial production.